Accepted
at 12:32 a.m. Jan, 24, 2026
by
Ahmed7
Bulk Suggestion
Bulk ID:
hunterlea91/01.14.26-04:33PM
Author:
hunterlea91
Co-authors:
Ahmed7
Rationale for change
NN video platelet disorders: https://youtu.be/i_c8x7TiHN0?si=sgt6pHdaCyiYjgxq
No changes in fields
Text
What is the recommended treatment for patients that develop heparin-induced thrombocytopenia?
{{c1::Discontinue heparin, begin a nonheparin anticoagulant (e.g., a direct thrombin inhibitor, fondaparinux)}}
{{c1::Discontinue heparin, begin a nonheparin anticoagulant (e.g., a direct thrombin inhibitor, fondaparinux)}}
Extra
- Warfarin should NOT be used in the acute management of HIT (only transition to warfarin once the platelet count has recovered (> 150k))
- If HIT is suspected, all heparin products (including heparin flushes) should be discontinued immediately and for LIFE, and anticoagulation should be initiated with a nonheparin medication (e.g., argatroban, fondaparinux)
- If HIT is suspected, all heparin products (including heparin flushes) should be discontinued immediately and for LIFE, and anticoagulation should be initiated with a nonheparin medication (e.g., argatroban, fondaparinux)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy




Watch Heparin, LMWH, Fondaparinux, Direct Thrombin Inhibitors, Xa Inhibitors


Watch Quantitative Platelet Disorders




Watch Heparin, LMWH, Fondaparinux, Direct Thrombin Inhibitors, Xa Inhibitors



Sketchy 2




Watch DVT SOAP




Watch DVT SOAP
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
OME
Additional Resources
One by one
Empty field
